Is the US prepared to deal with another pandemic or widespread health crisis?
The White House report and GHS Index portray strong US preparedness, while GAO, the Bipartisan Commission on Biodefense and others describe serious gaps and vulnerability.
No, the US is only partially prepared—better equipped in some areas than before COVID-19 due to stockpile rebuilds, surveillance upgrades, experience, and institutional changes, but significant gaps in sustained funding, workforce, coordination, and implementation of lessons learned leave it vulnerable to another major pandemic or widespread crisis.[1]
Improvements Since COVID-19
The Biden-Harris Administration and prior efforts addressed some glaring pre-2020 weaknesses:
COVID experience itself built operational knowledge, private-sector partnerships, and mRNA/platform technologies for faster countermeasures.
Persistent and Emerging Gaps
Multiple independent assessments highlight incomplete progress and risks of backsliding:
Bottom Line
The US has stronger stockpiles, better data systems in places, proven rapid MCM development potential, and hard-won experience compared to 2019. It can handle moderate outbreaks or known threats (as with mpox or contained H5N1) better than before. However, for a severe, novel, or highly transmissible pandemic—especially one straining hospitals, supply chains, and trust simultaneously—experts (GAO, Bipartisan Commission, public health leaders) assess it as inadequately prepared due to incomplete lesson implementation, fragile sustained funding/workforce, and coordination gaps.[10]
Preparedness is a continuous process requiring political will, stable multi-year funding for public health infrastructure (beyond emergency supplements), clearer authorities, resilient supply chains, and whole-of-society engagement. Without addressing these, the US risks repeating or worsening COVID-scale outcomes. Recent funding and staffing trends in 2025–2026 appear to reverse some post-COVID gains, heightening concerns. Ongoing monitoring of threats like H5N1, plus investments in platforms (mRNA, diagnostics), provide a foundation, but experts emphasize that “immediate action” and sustained commitment are still required.
Citations (10)
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “No, the US is only partially prepared—better equipped in some areas than before COVID-19 due to stockpile rebuilds, surveillance upgrades, experience, and institutional changes, but significant gaps in sustained funding, workforce, coordination, and implementation of lessons learned leave it vulnerable to another…”
evidence, official document, points to yes. Claim: SNS was dramatically restocked, electronic case reporting expanded, and OPPR created; the US is better equipped than before COVID-19.
- https://ghsindex.org/country/united-states/
Backs: “A 2024 Joint External Evaluation (JEE) under International Health Regulations and 2024 SPAR self-assessment showed relatively strong capacities (SPAR overall around 84%), though with recommendations for better alignment across federal/state/local levels and addressing gaps.”
statistic, data page, points to yes. Claim: US ranked #1 on the Global Health Security Index (83.5/100); JEE and SPAR self-assessment showed relatively strong capacities.
- https://www.aspr.gov/readiness-response/responses/asprs-response-h5n1-bird-flu
Backs: “Human cases remained limited (dozens reported, mostly occupational, low general public risk as of mid-2025 updates), with emergency response later deactivated as activity declined.”
evidence, official document, points to yes. Claim: H5N1 response involved coordinated surveillance, PPE distribution, antiviral stockpiles and limited human cases.
- https://www.gao.gov/products/gao-24-107175
Backs: “Boom-bust funding (surge during crises, cuts afterward) makes infrastructure and workforce gains temporary.”
statistic, official document, points to no. Claim: Hundreds of GAO COVID recommendations remain open; HHS emergency leadership is on the High-Risk List; boom-bust funding undermines gains.
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Sustained “on all the time” investment is needed rather than reactive spending.”
attribution, official document, points to no. Claim: Bipartisan Commission on Biodefense says the US remains dangerously vulnerable and needs sustained investment.
- https://www.gao.gov/products/gao-24-105891
Backs: “Burnout, recruitment/retention issues, and state/local variations persist.”
evidence, official document, points to no. Claim: Chronic public health underfunding, temporary COVID funds eroding, and workforce reductions weaken infrastructure.
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Hospital and broader system strains from concurrent threats (e.g., weather disasters as “threat multipliers”) are noted in national preparedness reports.”
evidence, article, points to no. Claim: Coordination problems, political polarization, declining trust, supply chain dependence and disparities hinder response.
- https://www.gao.gov/products/gao-23-105713
Backs: “Recent policy shifts (e.g., on certain research or vaccine contracts) and funding volatility raise questions about long-term readiness.”
evidence, official document, points to no. Claim: Medical countermeasure manufacturing, rapid scale-up and stockpiling lag; funding volatility raises readiness questions.
- https://features.csis.org/US-bird-flu-response/
Backs: “While contained so far, experts noted lagging data transparency, incomplete farm surveillance/testing early on, coordination challenges, and limited vaccine doses relative to population needs. Some vaccine development funding faced cuts.”
evidence, article, points to no. Claim: H5N1 critiques: lagging data transparency, incomplete early farm testing, coordination challenges, limited vaccine doses.
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “However, for a severe, novel, or highly transmissible pandemic—especially one straining hospitals, supply chains, and trust simultaneously—experts (GAO, Bipartisan Commission, public health leaders) assess it as inadequately prepared due to incomplete lesson implementation, fragile sustained funding/workforce, and…”
attribution, article, points to no. Claim: Experts assess the US as inadequately prepared for a severe, novel pandemic due to funding, workforce and coordination gaps.